Ann: Update on Mernova Sales License, page-2

Creso Pharma’s CEO and Co-Founder Dr Miri Halperin Wernli, commented:“We are pleased to have completed this due diligence process very quickly as it now allows us to shift our attention back to selling our high-quality cannabis products.“Mernova has an exciting opportunity ahead to cement a robust retail footprint in what is a rapidly expanding Canadian market and we are moving promptly to capture this value for our shareholders.“I look forward to providing further updates on sales progress over the coming weeks.”



Hopefully we will see some sales update soon!